Truffle Capital Unveils the Results of the 14th Truffle 100 Ranking: Software Companies Approach the Next Investment Cycle With Confidence
Truffle Capital unveils the results of its 14th Truffle 100 ranking. This is the barometer that is most frequently followed by software companies, and the most consistent software trends observatory.
Carried out in partnership with Teknowlogy, the study paints a picture of a group of French companies in good health, with good growth prospects, looking to the future with confidence.
- Confidence in the future, because software companies are continuing to invest heavily in R&D and, in anticipation of future growth, are recruiting researchers.
- Confidence in the potential of the French ecosystem, as 75% of managers surveyed do not expect to relocate their business (compared to 70% last year).
- Confidence in their capacity to find finance for their growth plans. The numerous delistings show that software companies are finding the investment resources they need in other finance niches, where procedures take better account of the valuations and specific features of their operations.
While growth in turnover was only 3%, taking it to €9.3 billion, with investment of €1.2 billion in R&D over the year, profits increased by 4.6%. These figures show that the long history of almost uninterrupted growth highlighted by the Truffle 100 since 2004 is continuing.
Dassault Systèmes, Sopra Steria and Murex take the top three spots in the ranking, accounting between them for total turnover from publishing of €5.4 billion, and reflecting a trend towards consolidation within the sector.
Disaffection with the stock exchange is apparent. Since 1 January 2019, we have seen the exit of Harvest (in 52nd place) and Coheris (in 78th place), bringing the number of listed companies down to 14, its lowest historic level since the creation of the Truffle 100.
Bernard-Louis Roques, General Manager and Co-founder of Truffle, commented on the results: 'Business growth demonstrates that the sector is highly resilient. Not only are French software companies growing more rapidly than GDP, but their investment in jobs and R&D is growing faster than their sales. This continuous focus on investment, particularly in research, and the resistance to relocation are helping French technology to flourish, translating into confidence in its ability to build future growth. From this viewpoint, the fact that ten of them have been delisted over two years reflects two things: software companies are not satisfied with the valuation the market gives them, and they know they are supported by strategic shareholders, particularly from the private equity sphere, who are ready to invest. No doubt many surprises lie in store over the coming years, and Truffle Capital, through the Truffle 100, will be best placed to monitor them.'
The 14th edition of the Truffle 100, and rankings from previous years, are available at:
https://www.truffle100.com/index.html
******
About Truffle Capital
Established in 2001, Truffle Capital is an independent European venture capital company, specializing in life sciences (BioTech and MedTech) and breakthrough technologies in the IT sectors (FinTech and InsurTech). Truffle Capital’s mission is to support the creation and development of young innovative companies capable of becoming tomorrow’s leaders. Headed by Patrick Kron, alongside Dr Philippe Pouletty and Bernard-Louis Roques, Co-founders and General Managers, Truffle Capital manages assets of €500 million. Since it was created, it has raised nearly €1 billion and has supported over 75 companies in the digital technology and life sciences sectors. At the end of 2017, Truffle Capital successfully closed its first two new institutional funds, Truffle Financial Innovation Fund and Truffle BioMedTech Fund, and also closed an RIF (retirement income fund).
For more information: www.truffle.com – Twitter: @trufflecapital
The original source-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the source-language text, which is the only version of the text intended to have legal effect.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190725005314/en/
Contact information
Maud Lazare | maud@truffle.com
DGM Conseil | +33 1 40 70 11 89
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Everen Specialty Appoints Carla Greaves Chief Underwriting Officer25.4.2025 20:00:00 EEST | Press release
Everen Specialty, a Bermuda-based (re)insurer for energy markets worldwide, today announced the appointment of Carla Greaves as its new Chief Underwriting Officer (CUO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425273777/en/ Carla Greaves Ms. Greaves will join the Executive Leadership Team of the Everen Group, based in the Bermuda office, later this year. She succeeds Jane Peterson, Interim CUO, who will continue in a consultancy capacity to facilitate the transition. With more than 30 years of underwriting and leadership experience in the (re)insurance industry, Ms. Greaves brings a wealth of expertise and a proven track record of success in the Casualty market where she is recognized for building high-performing teams, driving profitable growth, and successfully navigating complex market environments. Prior to joining Everen Specialty, Ms. Greaves held increasingly senior leadership positions, most recently servin
Incyte to Highlight Early-Stage Oncology Data at American Association for Cancer Research Annual Meeting 202525.4.2025 15:00:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced that the Company will present new early-stage data from its oncology portfolio at the American Association of Cancer Research (AACR) Annual Meeting 2025 in Chicago, IL, from April 25–30. “At AACR we will be presenting data from early-stage programs across our oncology portfolio, including for patients with myeloproliferative neoplasms, ovarian cancer and other solid tumors,” said Pablo J. Cagnoni, M.D., President and Head of Research and Development, Incyte. “These data will guide our approach as we advance our pipeline and seek to transform the treatment landscape for patients with cancer and myeloproliferative neoplasms.” Abstracts accepted for presentation at AACR include: Mini Symposium INCB177054 INCB177054: A Novel, Potent, Orally Bioavailable DGKα/ζ Dual Inhibitor Enhances T-Cell Function and Demonstrates Potent Antitumor Activity (Session Title: Novel Antitumor Agents. April 28, 4:50 p.m. – 5:05 p.m. ET (3:50 p.m. – 4:05 p.m. CT). Abstract #
SLB Announces First-Quarter 2025 Results; Remains Committed to Return a Minimum of $4 Billion to Shareholders in 202525.4.2025 13:50:00 EEST | Press release
SLB (NYSE: SLB) today announced results for the first-quarter 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250423635499/en/ The exterior of the SLB headquarters in Houston, Texas. First-Quarter Results (Stated in millions, except per share amounts) Three Months EndedChange Mar. 31, 2025 Dec. 31, 2024 Mar. 31, 2024 Sequential Year-on-year Revenue $8,490 $9,284 $8,707 -9% -3% Income before taxes - GAAP basis $1,063 $1,387 $1,357 -23% -22% Income before taxes margin - GAAP basis 12.5% 14.9% 15.6% -241 bps -306 bps Net income attributable to SLB - GAAP basis $797 $1,095 $1,068 -27% -25% Diluted EPS - GAAP basis $0.58 $0.77 $0.74 -25% -22% Adjusted EBITDA* $2,020 $2,382 $2,057 -15% -2% Adjusted EBITDA margin* 23.8% 25.7% 23.6% -186 bps 18 bps Pretax segment operating income* $1,556 $1,918 $1,649 -19% -6% Pretax segment operating margin* 18.3% 20.7% 18.9% -232 bps -60 bps Net income attributable to SLB, excluding charges &
Corona, The World’s Most Valuable Beer Brand 1 , Announces Its 100-Year Anniversary with Global Celebration25.4.2025 11:00:00 EEST | Press release
Today, Corona proudly celebrates its 100-year anniversary, a remarkable milestone for the iconic brand that has been synonymous with the beach and enjoyed by consumers worldwide for the past century. Since 1925, Corona has cultivated a deep association with the beach; fully embodying a lifestyle connected to nature and relaxation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425804516/en/ Corona 100 This Is Living Since 1925 In honor of the occasion, Corona invites everyone to live their “beach side” – a.k.a. their best side – at top-tier beach locations across the globe. The Corona 100 platform includes a film highlighting 100 years of beach culture, a definitive list of the top 100 beaches in the world to visit, and a signed multi-year sponsorship of a renowned concert at Copacabana Beach in Rio de Janeiro — all offering people across the globe opportunities to connect with their beach side. “For 100 years, Corona has
Ant Group Unveils New Recruitment Initiative for Top AI Talents, Ramping Up AI Innovation Efforts25.4.2025 10:28:00 EEST | Press release
Ant Group today unveiled Plan A, a new recruitment initiative to attract top artificial intelligence researchers, reinforcing its commitment to accelerating AI research and development under the “AI First” corporate strategy. Operating within the framework of Ant Star—Ant Group’s year-round campus recruitment program—Plan A specifically targets AI talents who are ambitious, adaptable, altruistic, and analytical. Outstanding graduates from universities worldwide with STEM majors are encouraged to apply for Plan A. Relevant fields include computer science, software engineering, artificial intelligence, cybersecurity, information and telecommunication engineering, mathematics, statistics, and other emerging interdisciplinary areas. To better foster the development of technological innovators in this new AI era, Plan A offers candidates comprehensive support and resources, including unrestricted access to AI hardware and tailored career paths that allow for significant research freedom. Ad
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom